FDA issued a Warning Letter to Agila Specialties Private Limited on 9/9/2013 as a result of this inspection.
483 Mylan Labs Limited, Speciality Formulation Facility Jun 2013

483 Mylan Labs Limited, Speciality Formulation Facility Jun 2013

Peter Baker FDA, Harry Brewer FDA$119.00 - Available Now

FDA investigators audited the Mylan Labs Limited, Speciality Formulation Facility - Bangalore, India facility and issued 13 inspectional observations (via FDA 483) on 27 Jun 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 13
  • Inspection end: 27 Jun 2013
  • Location: Bangalore, India
  • FEI: 3007648351
Add To Cart